Millie Das, MD

Medical Oncologist

Millie Das, MD, is a medical oncologist at Stanford University/VA Palo Alto Health Care System in Palo Alto, California, specializing in thoracic oncology with a clinical research focus on small cell lung cancer and novel immunotherapy strategies. She is a co-chair of the San Francisco Lung Cancer Conference and is a national leader in SCLC.

Published Articles (1)

Small Cell Lung Cancer in 2026: Consolidation IO Is Standard, Tarlatamab Has Full Approval, and the Maintenance Era Has Arrived

November 4, 2026

SCLC in 2026: consolidation durvalumab is standard in limited-stage disease, tarlatamab has full FDA approval, lurbinectedin maintenance is available, and antibody-drug conjugates are advancing in late-stage trials.